Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 30.30
+0.40 (1.34%)
At close: Jul 9, 2026
Apex Biotechnology Market Cap
Apex Biotechnology has a market cap or net worth of 3.03 billion as of July 9, 2026. Its market cap has increased by 5.03% in one year.
Market Cap
3.03B
Enterprise Value
2.47B
Revenue
1.91B
Ranking
n/a
PE Ratio
16.73
Stock Price
30.30
Market Cap Chart
Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 3.03B, an increase of 112.53%. That is a compound annual growth rate of 3.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.03B | -0.49% |
| Dec 31, 2025 | 3.04B | 1.16% |
| Dec 31, 2024 | 3.01B | -25.31% |
| Dec 29, 2023 | 4.03B | 57.73% |
| Dec 30, 2022 | 2.55B | -1.73% |
| Dec 30, 2021 | 2.60B | 10.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 3.68B |
| Sagittarius Life Science | 3.52B |
| SYN-TECH Chem. & Pharm. | 3.33B |
| BioGend Therapeutics | 3.27B |
| Shine-On BioMedical | 3.23B |
| Energenesis Biomedical CO.,LTD. | 3.17B |
| Chunghwa Chemical Synthesis & Biotech | 3.05B |
| Intech Biopharm | 2.93B |